Taurine Supplementation in Long COVID

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

February 29, 2028

Study Completion Date

December 31, 2028

Conditions
Long COVID
Interventions
DRUG

Taurine

Taurine is a naturally occurring amino sulfonic acid commonly found in the body. It is marketed as a natural health product/supplement and plays an important role in the body.

DRUG

Placebo

The placebo capsule is visually identical to the taurine capsule.

Trial Locations (1)

T6G 2B7

University of Alberta Hospital, Kaye Edmonton Clinic, Edmonton

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

University Health Network, Toronto

OTHER

lead

University of Alberta

OTHER